Company Profile
RXDX Stock Price, News & Analysis
- Ticker:
- RXDX
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Why the stock is moving
Current closing-price context is not available for RXDX.
Company overview
Business overview
Prometheus Biosciences was an immunology-focused biotechnology company centered on precision medicine for inflammatory bowel disease before being acquired by Merck. Its story was built around translating biomarker-driven biology into targeted treatments.
Geographic Base and Sector Classification
Prometheus was headquartered in the United States and traded on NASDAQ before the acquisition. It sat in immunology and precision biotechnology.
Business Model Characteristics
The company’s value was driven by clinical readouts, biomarker strategy, and the potential to create a differentiated treatment path in inflammatory disease. Investors watched data quality, target validation, and the strategic interest in its platform.
Position Within the Biotechnology Landscape
Prometheus was a premium precision-immunology biotech and one of the more compelling catalyst-driven names of its era. Since it has been acquired, it is now part of biotech M&A history rather than the live public-company universe.
Future catalysts
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What does RXDX do?
Prometheus Biosciences was an immunology-focused biotechnology company centered on precision medicine for inflammatory bowel disease before being acquired by Merck. Its story was built around translating biomarker-driven biology into targeted treatments.
On which exchange is RXDX stock listed?
RXDX (RXDX) is associated with NASDAQ, United States, Biopharma.
What is Prometheus?
Prometheus Biosciences was an immunology-focused biotechnology company centered on precision medicine for inflammatory bowel disease before being acquired by Merck.
Which conditions is RXDX targeting with Prometheus?
RXDX is associated with immunology based on its company overview and current catalyst commentary.
What is Biosciences?
Prometheus Biosciences was an immunology-focused biotechnology company centered on precision medicine for inflammatory bowel disease before being acquired by Merck.
What is Merck?
Prometheus Biosciences was an immunology-focused biotechnology company centered on precision medicine for inflammatory bowel disease before being acquired by Merck.